Schedule 13D ownership disclosure

SORRENTO THERAPEUTICS IN

Security class unavailable · CUSIP: 83587F202

Event date: 2016-05-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,499,936
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-16-001006
Form type
SC 13D/A
Filer
Sorrento Therapeutics, Inc.
CIK
CIK 850261
Filed
May 06, 2016
Reporting period
May 05, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub